“Two-birds-one-stone” oral nanotherapeutic designed to target intestinal integrins and regulate redox homeostasis for UC treatment | Science Advances
A “two-birds-one-stone” oral nanotherapeutic improves colitis via heparin-integrin interaction and ROS scavenging.